Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Low-Dose Acetylsalicylic Acid for Reduction of Breast Density and Inflammation
2017-000317-22Phase 2Completed
- Sponsor
- Linköping University
- Start
- Feb 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of aspirin in None and mastitis (2 arms), sponsored by Linköping University. Primary endpoints: IL-6 levels in breast extracellular fluid, IL-8 levels in breast extracellular fluid and 1 more. Started Feb 2017; status: completed.
02
Drugs
aspirin
03
Conditions
mastitis
Beyond the preview
Go deeper on 2017-000317-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000317-22.